Table 3. PillCam Transit Times Stratified by Patient Demographics (Minutes + Standard Deviation)*.
*Excludes four patients whose pill never exited the stomach. Numbers for each group listed next to transit times. Clinical and/or transit time data was not available for all patients in the charts reviewed.
** No relationship between the stage of CKD and gastric transit time (Kruskal-Wallis, p = 0.48)
*** No relationship between the stage of CKD and small bowel transit time (Kruskal-Wallis, p = 0.13)
BMI: body mass index; CHF: congestive heart failure; CKD: chronic kidney disease; n: number; ns: not significant
| Gastric Transit Time | p-value | Small Bowel Transit Time | p-value | |
| Albumin | ||||
| > 3 gm/dl | 37 ± 53 (n = 123) | 237 ± 81.4 (n = 98) | ||
| < 3 gm/dl | 27 ± 30 (n = 36) | p = 0.3 | 240.6 ± 111.4 (n = 26) | p = ns |
| > 2 gm/dL | 37.7 ± 52.2 (n = 109) | 227.9 ± 78.9 (n = 81) | ||
| < 2 gm/dL | 16.7 ± 20.3 (n = 7) | p = 0.8 | 245 ± 214.4 (n = 4) | p = ns |
| No CKD | 47.8 ± 78.4 (n = 102) | 246.6 ± 83.7 (n = 74) | ||
| CKD Stages 2-5 | 44.3 ± 82.7 (n = 48) | p = 0.3 | 225 ± 97.3 (n = 38) | p = ns |
| CKD 2 | 11 ± 1.4 (n = 2) | 182 ± 43 | ||
| CKD 3 | 27.8 ± 22 (n = 23) | 244 ± 107 | ||
| CKD 4 | 23.7 ± 28 (n = 10) | 254 ± 87 | ||
| CKD 5 | 34.7 ± 39 (n = 11)** | 164 ± 75*** | ||
| BMI > 30 | 33.2 ± 41.4 (n = 81) | 244.89 ± 88.0 (n = 69) | ||
| BMI < 30 | 36.6 ± 56.2 (n = 78) | p = 0.8 | 229.09 ± 88.0 (n = 55) | p = ns |
| HbA1c > 6.5% | 37 ± 27 (n = 13) | 254 ± 105 (n = 11) | ||
| HbA1c < 6.5% | 40 ± 53 (n = 38) | p = 0.1 | 224 ± 94 (n = 27) | p = ns |
| Systolic CHF | 45 ± 28 (n = 19) | 246 ± 86 (n = 16) | ||
| No systolic CHF | 35 ± 53 (n = 125) | p = 0.003 | 238 ± 90 (n = 96) | p = ns |